Enhancing Fluorescence Guided Surgery with Nanobodies and Fluorescence Lifetime Imaging

This presentation explores enhancing fluorescence-guided surgery with Nanobodies — targeted agents offering rapid pharmacokinetics and tumor specificity — and demonstrates how fluorescence lifetime imaging adds biological insights and reduces non-specific signals compared to conventional fluorescence methods.

About the Speaker

Sophie Hernot, a bioengineer with a PhD in Medical Sciences, is a leading professor in the Molecular Imaging and Therapy research group at Vrije Universiteit Brussel, Belgium. Her research centers on developing, preclinically validating and clinically translating fluorescent and radiolabeled Nanobody-based tracers for image-guided applications. As the academic director of the In vivo Cellular and Molecular Imaging Core Facility, she also promotes the adoption of innovative imaging techniques across diverse research fields, enhancing in vivo understanding of biological processes.